+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurology Devices: Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141150

Global Neurology Devices Market to Reach $15.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Neurology Devices estimated at US$10.3 Billion in the year 2020, is projected to reach a revised size of US$15.3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$5.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Neurostimulation segment is readjusted to a revised 6.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 10.1% CAGR

The Neurology Devices market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2 Billion by the year 2027.

Interventional Neurology Segment to Record 6% CAGR

In the global Interventional Neurology segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.4 Billion in the year 2020 will reach a projected size of US$2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.4% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Neurology Devices

What is the estimated value of the Global Market for Neurology Devices?

The Global Market for Neurology Devices was estimated to be valued at $10.3 Billion in 2020.

What is the growth rate of the Global Market for Neurology Devices?

The growth rate of the Global Market for Neurology Devices is 5.8%, with an estimated value of $15.3 Billion by 2027.

What is the forecasted size of the Global Market for Neurology Devices?

The Global Market for Neurology Devices is estimated to be worth $15.3 Billion by 2027.

Who are the key companies in the Global Market for Neurology Devices?

Key companies in the Global Market for Neurology Devices include Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Johnson & Johnson, Medtronic, Inc., MicroPort Scientific Corporation, Nihon Kohden Corporation, Penumbra, Inc. and Stryker Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Neurology Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Cerebrospinal Fluid Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Cerebrospinal Fluid Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Neurosurgery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Neurosurgery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Neurosurgery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: USA Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 19: USA 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 21: Canada Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 22: Canada 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
JAPAN
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: Japan Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 25: Japan 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
CHINA
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 27: China Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 28: China 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
EUROPE
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 30: Europe Historic Review for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 31: Europe 15-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
  • Table 32: Europe Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 33: Europe Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 34: Europe 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
FRANCE
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: France Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 37: France 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
GERMANY
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 39: Germany Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 40: Germany 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Italy Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 43: Italy 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
UNITED KINGDOM
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 45: UK Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 46: UK 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
SPAIN
  • Table 47: Spain Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Spain Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 49: Spain 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
RUSSIA
  • Table 50: Russia Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 51: Russia Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 52: Russia 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
REST OF EUROPE
  • Table 53: Rest of Europe Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: Rest of Europe Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 55: Rest of Europe 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
ASIA-PACIFIC
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 58: Asia-Pacific 15-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Neurology Devices by Segment - Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 61: Asia-Pacific 15-Year Perspective for Neurology Devices by Segment - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices and Neurostimulation Devices for the Years 2012, 2021 & 2027
AUSTRALIA
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation